7月16日A股投資避雷針︱西藏珠峯:控股股東收到證監會立案告知書;恆立退:公司股票終止上市暨摘牌
中復神鷹股東連工投擬減持不超1%股份;恆鋒信息控股股東、實控人之一魏曉曦及其一致行動人擬合計減持不超3%;三維天地股東北京維恆、三維智鑑等擬減持合計不超4.07%股份;天元股份股東天祺股權投資、董事羅耀東及其配偶鄒芳擬減持合計不超1%股份;浩雲科技董事長兼總經理雷洪文擬減持不超過400萬股;凌志軟件股東華達啓富、達盈智匯、華富智匯擬合計減持約不超2.1%股份;杭州銀行股東中國人壽擬減持合計不超過5078.94萬股;方正科技股東新方正控股擬減持不超過2.27%股份;西藏珠峯控股股東收到證監會立案告知書;恆立退公司股票終止上市暨摘牌

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.